Managed Healthcare Executive May 3, 2024
Peter Wehrwein, Managing Editor

Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president.

Optum Rx has reached an agreement with the manufacturers of the approved glucagon-like peptide 1 (GLP-1s) drugs that will allow health plans to tier access to the drugs and still receive a rebate.

In an interview with Managed Healthcare Executive (MHE) at the Asembia specialty pharmacy meeting in Las Vegas this week, Jon Mahrt, president and chief operating officer of Optum Rx, said that rebates have been contingent upon health plans covering according to criteria included in the FDA-approved label.

Mahrt...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Payer, Pharma, Pharma / Biotech
Expert Discusses Pharmacy Deserts, Expanding Pharmacy Access
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Q&A: PBM Legislation “Highly Likely” to Pass This Year
Medicare’s Drug Price Negotiations Could Impact Physician Reimbursement
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal

Share This Article